REAL-WORLD CLINICAL AND PATIENT-REPORTED OUTCOME DATA OF PATIENTS WITH NEWLY DIAGNOSED, ADVANCED OVARIAN CANCER - THE GERMAN PROSPECTIVE, NON-INTERVENTIONAL SCOUT-1 STUDY (NOGGO ov54, NCT04830709)

被引：0
|
作者：
Arndt, Tjadina [1 ,2 ]
Pietzner, Klaus [1 ,2 ]
Braicu, Elena Ioana [1 ,2 ]
Wimberger, Pauline [1 ,3 ]
Rose, Matthias [4 ]
Sehouli, Jalid [1 ,2 ]
机构：
[1] North Eastern German Soc Gynecol Oncol NOGGO, Berlin, Germany
[2] Charite Med Univ, Dept Gynecol, European Competence Ctr Ovarian Canc, Berlin, Germany
[3] Univ Hosp Carl Gustav Carus, Dept Gynecol & Obstet, Dresden, Germany
[4] Charite Med Univ, Dept Psychosomat Med, Ctr Internal Med & Dermatol, Berlin, Germany
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 07期
关键词：
Advanced ovarian cancer; BRCA; real-world conditions; standard of care; patient-reported outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DP06
引用
收藏
页码：3367 / 3368
页数：2
相关论文
共 15 条
  • [1] First Interim Analysis of the SCOUT-1 Study (NOGGO ov54, NCT04830709): A Non-Interventional Study to evaluate Treatment Patterns and Longterm Outcome in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Pietzner, Klaus
    Braicu, Elena Ioana
    Wimberger, Pauline
    Goldmann, Jessika
    Kubiak, Karol
    De Gregorio, Nikolaus
    Radosa, Julia
    Aktas, Bahriye
    Ober, Angelika
    Brucker, Cosima
    Meyer-Wilmes, Philipp
    Melekian, Badrig
    Sagasser, Jacqueline
    Guth, Dagmar
    Schnelzer, Andreas
    Tchaikovski, Svetlana
    Lampe, Bjorn
    Diemert, Svenja
    Sehouli, Jalid
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 90 - 91
  • [2] Biomarker testing in patients with newly diagnosed advanced ovarian cancer - results from the first interim analysis of the non-interventional SCOUT-1 study (NOGGO Ov54, NCT04830709)
    Braicu, Elena Ioana
    Wimberger, Pauline
    Pietzner, Klaus
    Goldmann, Jessika
    Kubiak, Karol
    Gregorio, Nikolaus De
    Radosa, Julia Caroline
    Aktas, Bahriye
    Ober, Angelika
    Brucker, Cosima
    Meyer-Wilmes, Philipp
    Melekian, Badrig
    Sagasser, Jacqueline
    Guth, Dagmar
    Schnelzer, Andreas
    Tchaikovski, Svetlana
    Lampe, Bjoern
    Hanf, Volker
    Diemert, Svenja
    Sehouli, Jalid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A289 - A290
  • [3] FIRST INTERIM ANALYSIS OF THE SCOUT-1 STUDY (NOGGO OV54, NCT04830709): A NON-INTERVENTIONAL STUDY TO EVALUATE TREATMENT PATTERNS AND LONGTERM OUTCOME IN PATIENTS WITH NEWLY DIAGNOSED ADVANCES OVARIAN CANCER
    Pietzner, Klaus
    Braicu, Elena Ioana
    Wimberger, Pauline
    Goldmann, Jessika
    Kubiak, Karol
    De Gregorio, Nikolaus
    Radosa, Julia Caroline
    Atkas, Bahriye
    Ober, Angelika
    Brucker, Cosima
    Meyer-Wilmes, Philipp
    Melekian, Badrig
    Sagasser, Jacqueline
    Guth, Dagmar
    Schnelzer, Andreas
    Tchaikovski, Svetlana
    Veldink, Hendrik
    Lampe, Bjoern
    Sehouli, Jalid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A274 - A274
  • [4] REAL-WORLD TREATMENT, CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN CANCER: UP-DATE ON THE CUMULATIVE NUMBERS OF PATIENTS TREATED AT THE SITES (NOGGO OV54, NCT04830709)
    Sehouli, Jalid
    Arndt, Tjadina
    Pietzner, Klaus
    Braicu, Elena Iona
    Wimberger, Pauline
    Link, Theresa
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A247 - A247
  • [5] SCOUT-1: Prospective non-interventional study in patients with BRCA/HRD-tested ovarian cancer (OC) eligible for first-line (1L) platinum-based chemotherapy (NOGGO ov54).
    Wimberger, Pauline
    Pietzner, Klaus
    Braicu, Ioana
    Glowik, Regina
    Rose, Matthias
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] SCOUT-1: prospective non-interventional Study in BRCA/ HRD-tested Patients with newly-diagnosed Ovarian Cancer (OC) eligible for Platinum-based Chemotherapy
    Pietzner, Autoren K.
    Braicu, E., I
    Glowik, R.
    Rose, M.
    Wimberger, P.
    Sehouli, J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E141 - E141
  • [7] FIRST INTERIM ANALYSIS OF PATIENT-REPORTED OUTCOMES IN VIEW STUDY: A MULTICENTER, SINGLEARM, PROSPECTIVE, NON-INTERVENTIONAL STUDY OF VONOPRAZAN IN REAL-WORLD CLINICAL PRACTICE IN CHINA
    Xiao, Y.
    Wang, Q.
    Li, G.
    Nail, A.
    Song, Q.
    Xie, L.
    Chen, M.
    VALUE IN HEALTH, 2023, 26 (12) : S448 - S449
  • [8] Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
    Feist, Eugen
    Baraliakos, Xenofon
    Behrens, Frank
    Thaci, Diamant
    Klopsch, Thilo
    Plenske, Anja
    Blindzellner, Lisa K.
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 621 - 635
  • [9] Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
    Eugen Feist
    Xenofon Baraliakos
    Frank Behrens
    Diamant Thaçi
    Thilo Klopsch
    Anja Plenske
    Lisa K. Blindzellner
    Pascal Klaus
    Thomas Meng
    Peter-Andreas Löschmann
    Rheumatology and Therapy, 2022, 9 : 621 - 635
  • [10] Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
    Eugen Feist
    Xenofon Baraliakos
    Frank Behrens
    Diamant Thaçi
    Thilo Klopsch
    Anja Plenske
    Lisa K. Blindzellner
    Pascal Klaus
    Thomas Meng
    Peter-Andreas Löschmann
    Rheumatology and Therapy, 2023, 10 : 1809 - 1810
12